Dec 15, 2017 - BMO Capital Markets issues rating change for ABT
Dec 14, 2017 -
Dec 14, 2017 - In 2015, I skimmed 15 of the largest Dividend Achievers.Many would say that due to the underperformance of the mega caps, I set myself up for some meager returns.So what if I had instead skipped over
Dec 14, 2017 - Regeneron is significantly undervalued at current levels. Eli Lilly has provided guidance for 2018. Bluebird has announced a public offering.
Dec 13, 2017 - Analysts Take Action on Health Care Stocks, Stocks: ABT,AET,MDT,MYL, release date:Dec 13, 2017
Dec 13, 2017 - In early 2015 I created a portfolio (skimmed) from the Dividend Achievers Index.I selected 15 of the largest cap companies in that index.To date I've essentially tracked the returns of the underlying
Dec 13, 2017 - Intersect ENT's (XENT) consistent focus on the chronic sinusitis market is likely to lend the company a competitive edge in the niche space.
Dec 12, 2017 -
Abbott Laboratories (NYSE: ABT) had a busy 2017 after acquiring Alere and St. Jude Medical, earning the stock a nod of approval from a Wall Street analyst.
Dec 12, 2017 - Names on the move ahead of the open.
Dec 10, 2017 - The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. No doubt, these are